Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Design Therapeutics Inc (DSGN)

Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Design Therapeutics Inc 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 USA

www.designtx.com Employees: 54 P: 858-293-4900

Sector:

Medical

Description:

Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 581,602
Enterprise Value, $K 559,042
Shares Outstanding, K 56,964
Float, K 43,577
% Float 76.50%
Short Interest, K 2,232
Short Float 3.92%
Days to Cover 3.18
Short Volume Ratio 0.10
% of Insider Shareholders 23.50%
% of Institutional Shareholders 56.64%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -49,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,000 K
EBIT, $ -77,990 K
EBITDA, $ -83,590 K

Growth:

1-Year Return 105.43%
3-Year Return 27.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/05/25
Next Earnings Date 03/09/26
Earnings Per Share ttm -1.19
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year -30.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DSGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.56%
Return-on-Assets % -29.19%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.89
Book Value/Share 3.51
Interest Coverage -1.75
60-Month Beta 1.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar